Outcomes
The primary objective was to compare Secondary objectives were to compare the correct detection rates of the clinical investigators; to assess the correct detection rates of both radiotracers for PCa lesions in a region-based analysis; to report the impact on diagnostic thinking (impact of PET/CT result on posttest vs. pretest probability of a correct diagnosis), therapeutic decision making (impact on the comprehensive process by which physicians make decisions about the PCa response), and adequacy of management changes by the Investigators at 3 time points (before PET, immediately after both PET studies, and at the end of follow-up) and by the expert panel (only at the end of follow-up), using 3 dedicated forms (supplemental materials); to compare the masked intra- and interreader agreements; and to assess the safety profile of 